Mini reviewPublished 29 Mar 2024
Power of Pharmacogenomics in Depression Treatment
Department of Pharmacology, Universidad Federal do Rio de Janeiro, Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmacogenomics has emerged as a powerful tool in the treatment of depression, offering personalized approaches to medication selection and dosing based on individual genetic profiles. This abstract explores the role of pharmacogenomics in depression treatment, highlighting its potential to enhance efficacy, minimize adverse reactions, and expedite the path to effective symptom management. By understanding how genetic variations influence drug metabolism and response, clinicians can tailor treatment strategies to each patient, ultimately improving outcomes and revolutionizing mental health care. Despite challenges such as cost and accessibility, pharmacogenomics represents a promising avenue for precision medicine in depression treatment, paving the way for more targeted and personalized interventions in the quest for better mental health outcomes.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalWorld Journal of Pharmacology and Toxicology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Alexander Cornel”